Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Star
6835.0000 -9.50 (-0.14%)
NSE Jul 11, 2025 15:31 PM
Volume: 224.0K
 

6835.00
-0.14%
Axis Direct
Q4 revenue declined 3% YoY in line with our estimate, while EBITDA adjusted for Rs 290 mn of forex loss at Rs 3.9 bn was 9% below our estimate. Adj. PAT declined 10% YoY at Rs 2.88 bn, 12% below our estimate.
Number of FII/FPI investors increased from 826 to 922 in Mar 2025 qtr.
More from Divi's Laboratories Ltd.
Recommended